STRS Ohio’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-35,300
| Closed | -$331K | – | 2356 |
|
|
2020
Q3 | $331K | Sell |
35,300
-30,800
| -47% | -$293K | ﹤0.01% | 1530 |
|
|
2020
Q2 | $505K | Sell |
66,100
-11,000
| -14% | -$84.2K | ﹤0.01% | 1300 |
|
|
2020
Q1 | $476K | Buy |
77,100
+27,000
| +54% | +$238K | ﹤0.01% | 1172 |
|
|
2019
Q4 | $609K | Hold |
50,100
| – | – | ﹤0.01% | 1327 |
|
|
2019
Q3 | $578K | Sell |
50,100
-17,300
| -26% | -$182K | ﹤0.01% | 1160 |
|
|
2019
Q2 | $673K | Buy |
67,400
+16,000
| +31% | +$173K | ﹤0.01% | 1042 |
|
|
2019
Q1 | $662K | Buy |
51,400
+11,900
| +30% | +$177K | ﹤0.01% | 1052 |
|
|
2018
Q4 | $600K | Buy |
39,500
+1,600
| +4% | +$30.5K | ﹤0.01% | 1076 |
|
|
2018
Q3 | $758K | Sell |
37,900
-1,500
| -4% | -$34.1K | ﹤0.01% | 1074 |
|
|
2018
Q2 | $768K | Sell |
39,400
-1,500
| -4% | -$33.2K | ﹤0.01% | 1107 |
|
|
2018
Q1 | $824K | Sell |
40,900
-10,100
| -20% | -$171K | ﹤0.01% | 977 |
|
|
2017
Q4 | $675K | Buy |
51,000
+10,700
| +27% | +$161K | ﹤0.01% | 1166 |
|
|
2017
Q3 | $743K | Sell |
40,300
-1,400
| -3% | -$26.1K | ﹤0.01% | 1101 |
|
|
2017
Q2 | $767K | Buy |
41,700
+6,500
| +18% | +$129K | ﹤0.01% | 1004 |
|
|
2017
Q1 | $793K | Buy |
35,200
+8,400
| +31% | +$201K | ﹤0.01% | 966 |
|
|
2016
Q4 | $932K | Sell |
26,800
-6,600
| -20% | -$197K | ﹤0.01% | 881 |
|
|
2016
Q3 | $818K | Sell |
33,400
-1,800
| -5% | -$45K | ﹤0.01% | 922 |
|
|
2016
Q2 | $841K | Hold |
35,200
| – | – | ﹤0.01% | 902 |
|
|
2016
Q1 | $823K | Buy |
35,200
+3,500
| +11% | +$83.1K | ﹤0.01% | 900 |
|
|
2015
Q4 | $957K | Buy |
31,700
+8,000
| +34% | +$258K | ﹤0.01% | 836 |
|
|
2015
Q3 | $941K | Buy |
23,700
+11,100
| +88% | +$689K | ﹤0.01% | 858 |
|
|
2015
Q2 | $870K | Sell |
12,600
-6,900
| -35% | -$434K | ﹤0.01% | 953 |
|
|
2015
Q1 | $1.06M | Sell |
19,500
-2,500
| -11% | -$119K | ﹤0.01% | 760 |
|
|
2014
Q4 | $938K | Sell |
22,000
-9,900
| -31% | -$358K | ﹤0.01% | 829 |
|
|
2014
Q3 | $1.02M | Sell |
31,900
-4,900
| -13% | -$104K | ﹤0.01% | 749 |
|
|
2014
Q2 | $762K | Sell |
36,800
-1,800
| -5% | -$33.3K | ﹤0.01% | 965 |
|
|
2014
Q1 | $747K | Buy |
38,600
+3,800
| +11% | +$80.7K | ﹤0.01% | 913 |
|
|
2013
Q4 | $845K | Sell |
34,800
-6,500
| -16% | -$153K | ﹤0.01% | 860 |
|
|
2013
Q3 | $887K | Sell |
41,300
-1,500
| -4% | -$35.4K | ﹤0.01% | 919 |
|
|
2013
Q2 | $952K | Buy |
+42,800
| New | +$943K | ﹤0.01% | 877 |
|
STRS Ohio's AMAG Position: Q4 2020 in Review
STRS Ohio sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 35,300 shares — an estimated $331K sold.
STRS Ohio first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $1.06M in Q1 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- STRS Ohio reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- STRS Ohio sold 35,300 AMAG Pharmaceuticals shares in Q4 2020, an estimated $331K.
- STRS Ohio first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- STRS Ohio's AMAG Pharmaceuticals position peaked at $1.06M in Q1 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.